OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.7150
-0.0350 (-4.67%)
Oct 7, 2026, 4:10 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 26.24 million as of October 7, 2026. That makes OncoSil Medical the world's 37,832nd most valuable company and 1,014th in Australia. Its market cap has decreased by 18.24% in one year.
Market Cap
26.24M
Enterprise Value
19.78M
Revenue
5.09M
Global Rank
Country Rank
#1,014 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 26.24M, an increase of 259.75%. That is a compound annual growth rate of 6.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 26.24M | 43.21% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compumedics | 51.94M |
| HeraMED | 48.66M |
| Cleo Diagnostics | 47.30M |
| Micro-X | 46.65M |
| CleanSpace Holdings | 38.89M |
| Nova Eye Medical | 37.03M |
| Control Bionics | 33.13M |
| ImpediMed | 21.97M |